- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.04. | FDA seeks safety data for Lilly's oral GLP-1 Foundayo | ||
| 14.04. | FDA renews criticism of trial sponsors over transparency | ||
| 14.04. | Novo Nordisk partners OpenAI on R&D "transformation" | ||
| 14.04. | Travere claims first FDA OK in rare kidney disease FSGS | ||
| 14.04. | Revolution rockets on strong pancreatic cancer data | ||
| 14.04. | Alamar, Hemab, Kailera, and Seaport advance IPOs | ||
| 13.04. | IDEAYA/Servier PKC drug aces uveal melanoma trial | ||
| 13.04. | AI could spare bowel cancer patients from unneeded treatment | ||
| 13.04. | NICE update doubles eligible patients for AZ's Lokelma | ||
| 13.04. | Data backs GSK's ovarian cancer blockbuster hopes | ||
| 13.04. | FDA hands another rejection to Replimune's melanoma therapy | ||
| 10.04. | Senju launches first-in-class dry eye disease drug in Japan | ||
| 10.04. | Diagnostics lag is holding back new therapies, says study | ||
| 10.04. | Chinese trial backs base-editing drug for thalassaemia | ||
| 10.04. | Roche places a $1bn bet on C4T degrader-antibody conjugates | ||
| 10.04. | Boehringer transfers schizophrenia DTx selling rights to Click | ||
| 09.04. | Pulmonary fibrosis drug developer Avalyn files IPO | ||
| 09.04. | NHS risks missing out on independent prescriber benefits | ||
| 09.04. | AbbVie tries a new approach in 340B programme battle | ||
| 09.04. | 23andMe study explains variable results with obesity drugs | ||
| 09.04. | Syneron raises $150m for macrocyclics, and other financings | ||
| 09.04. | Syneron raises $150m for macrocylics, and other financings | ||
| 08.04. | Activist investor renews its criticism of Novavax | ||
| 08.04. | Jeito closes 'record' $1.2bn Europe-focused biopharma fund | ||
| 08.04. | EU invests €30m to fight antimicrobial resistance |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.